-
Acridine Orange hydrochloride Protocol Guide
2026-09-21
Acridine Orange hydrochloride (SKU B7747) provides cell-permeable, dual-emission staining for practical DNA and RNA differential staining, cell cycle analysis, and flow-based nucleic acid measurements. It should be validated in the intended cell system and used promptly after solution preparation rather than stored long term or used alone to make unsupported apoptosis or mechanistic claims.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe
2026-09-20
DiI (DiIC18(3)) provides orange-red plasma membrane labeling for live or fixed specimens, supporting neuronal tracing, migration, adhesion, fusion, and lipoprotein-labeling workflows. It is not water-soluble and should not be treated as a general organelle stain; solvent selection, light protection, and control of permeabilization are central to reproducible results.
-
Ribociclib Succinate: Reliable CDK4/6 Assays
2026-09-19
A practical, scenario-driven guide to using Ribociclib succinate (SKU B1084) in cell proliferation, viability, and cytotoxicity workflows. It covers solvent selection, pH-related handling, concentration-response design, data interpretation, and product-selection considerations for reproducible cancer research.
-
BI-1347 Workflow for CDK8/19 Studies
2026-09-19
Build a practical BI-1347 inhibitor workflow for target-dependent signaling, inflammatory cell models, transcriptomics, and antitumor research. The guide separates product-backed specifications from starting conditions that require optimization in each biological system.
-
From AML Mechanism to Plasmid Strategy
2026-09-18
The LMO2/LDB1 axis illustrates how mechanistic AML research can be strengthened by disciplined plasmid design, purification, and validation. This thought-leadership guide connects the study’s findings to practical, translational workflows using the ApexPrep DNA Plasmid Miniprep Kit.
-
Moxidectin: A Mechanistic Assay Roadmap
2026-09-18
Moxidectin is a macrocyclic lactone anthelmintic with established veterinary use and an emerging role in antifungal combination research. This article translates recent Candida albicans findings into a practical, evidence-aware framework for mechanism-driven assay design and interpretation.
-
Asymmetric Cu Nanozyme Reprograms AMI Inflammation
2026-09-17
This ACS Nano study develops a bromine-doped, asymmetrically coordinated copper single-atom nanozyme that improves reactive oxygen species elimination and reshapes inflammatory and regulatory immune responses after acute myocardial infarction. Its combination of coordination-engineering, density functional theory, cellular assays, and animal studies provides a mechanistic framework for linking nanozyme electronic structure with cardiac protection.
-
Torin2: From mTOR Inhibition to Cell Death
2026-09-17
A translational framework for using Torin2 to connect mTOR pathway suppression with apoptosis, transcription-independent cell death, model selection, and preclinical decision-making.
-
Moxidectin Potentiates Polyenes Against Oral Candidiasis
2026-09-16
The 2024 study shows that Moxidectin enhances amphotericin B and nystatin activity against Candida albicans by increasing fungal ergosterol biosynthesis and polyene binding. Combination treatment also reduced oral infection burden and mucosal inflammation in mice, supporting Moxidectin as a research candidate for polyene potentiation rather than as an established antifungal therapy.
-
LINC01977, Super-Enhancers, and SMAD3 in LUAD
2026-09-15
Zhang et al. identify a super-enhancer-driven LINC01977–SMAD3 circuit that links tumor-associated macrophage signals with malignant behavior in early-stage lung adenocarcinoma. The study combines epigenomic, chromatin-contact, functional, and in vivo evidence, providing a mechanistic framework for investigating canonical TGF-β signaling in tumor progression and related disease models.
-
mRNA Vaccine Protection Against H5N1 in Dairy Cows
2026-09-15
The reference study evaluates a hemagglutinin-based mRNA–lipid nanoparticle vaccine in high-yielding lactating dairy cows, addressing a major translational gap between experimental mRNA platforms and protection in a relevant livestock host. The vaccine was well tolerated, induced strong antibody responses, protected all immunized cattle after a high-dose H5N1 challenge, and retained substantial protection when serum antibody levels had declined.
-
Deferasirox Fe3+ Chelate in Myeloid Research
2026-09-14
This practical guide shows how to use Deferasirox Fe3+ chelate in iron, mitochondrial ROS, and myeloid differentiation workflows. It emphasizes chemical-form controls, oxygen-aware experimental design, and troubleshooting strategies that distinguish ferric-complex effects from free deferasirox activity.
-
Ivermectin Research Workflows for Parasitology
2026-09-14
Build mechanism-first parasite assays with Ivermectin by combining controlled solvent handling, motility readouts, viability measurements, and host-cell counterscreens. This guide also explains how findings from Gasdermin C research can inform assay design without overstating an unproven oncology application.
-
Vorinostat Workflows for HDAC and Apoptosis Research
2026-09-13
Build reproducible HDAC-inhibition experiments with Vorinostat, from concentration–response design to orthogonal apoptosis confirmation. The workflow also shows how the reference study’s live-cell HO-1 activity imaging can support a carefully controlled, hypothesis-generating extension into epigenetic regulation.
-
DAMGO: A Causal Probe of Opioid Pain Biology
2026-09-12
DAMGO is a selective µ-opioid receptor agonist for connecting receptor activation with tissue responses and pain behavior. This article presents an assay-centered framework for interpreting MOR signaling, mechanical hypersensitivity, and tolerance without conflating distinct experimental scales.